Immunology

Method Developed Predicts Disease Activity in Multiple Sclerosis
Multiple sclerosis, or MS, is an inflammatory disease of the central nervous system that mainly affects young adults and it is not currently possible to know which individuals with multiple sclerosis, a life-long condition, risk developing severe disease. More...28 Sep 2016

Novel Turbidimetric Immunoassay Evaluated for Fecal Calprotectin
Calprotectin is a multifunctional protein that plays an important role in the diagnosis and follow-up of inflammatory bowel disease and high levels of calprotectin in stool samples are associated with inflammation of the intestinal tract. More...28 Sep 2016

Optimal Rule-Out Biomarker Strategy Developed for Acute MI
Assessment of patients presenting to the Emergency Department (ED) with symptoms suggestive of acute coronary syndrome (ACS) represents a major clinical challenge, since the majority of patients do not have a final diagnosis of acute myocardial infarction (AMI). More...27 Sep 2016

Field Performance for Rapid Detection of Influenza Virus Analyzed
Clinical differentiation of influenza A virus from infections caused by influenza B virus and the other viruses is unreliable, however effective antiviral treatment is only available for influenza A virus infections and must be administered early in the course of disease to be effective. More...27 Sep 2016

POC Diagnostic Tool Introduced for Allergic Disorder Biomarker
Identifying patients with uncontrolled asthma mediated by immunoglobulin E remains an area of high unmet need and it is estimated that in Europe, more than 30 million people are affected by asthma, and approximately half of patients remain uncontrolled. More...20 Sep 2016

Sensitive Clinical Marker Defined for Ulcerative Colitis Evolution
The two main subtypes of inflammatory bowel diseases (IBD), Crohn’s disease (CD) and ulcerative colitis (UC) are characterized by episodes of inflammatory activity and remission and determination of disease activity remains challenging, with most clinical scores correlating poorly with the inflammatory state. More...20 Sep 2016

Combined Use of Assays Identifies Cancer Patient Response to Crizotinib
In screening of a large cohort for anaplastic lymphoma kinase (ALK) fusions through both fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) assays, researchers found many non-small cell lung cancer (NSCLC) patients who had negative and atypical FISH patterns accompanied with positive IHC results, who showed response to crizotinib treatment. More...19 Sep 2016
In Other News
Biomarker Outperforms Current Gold Standard to Detect Brain Shunt Infections
Circulating Immune Cells Act As Idiopathic Pulmonary Fibrosis Biomarkers
Guide Helps Physicians Diagnose and Manage Food Allergies
Lung Eosinophils Play Protective and Beneficial Role
Certification Enables Development of New Technology in Next-Gen Immunodiagnostics
Immune Analysis of Biopsies Predicts Response to Melanoma Immunotherapy
Innate Immune Sensor of Microbial Proteolysis Revealed
Latent Toxoplasmosis Prevalence Analyzed Retrospectively
Simplified Assay Quantifies Circulating Activated Protein C
Lateral Flow-Based Antibody Test Developed for Trachoma
Neutrophil CD64 Index Helps Diagnose Spontaneous Bacterial Peritonitis
Next-Generation Systems Introduced for Clinical Laboratories
High-Sensitivity Micro LC-MS/MS Assay Developed for Serum Estradiol
Immunoassay Evaluated for Quantitative Measurement of Fecal α1-Antitrypsin
Protein Microarray Detects Antibodies in Melioidosis Patients
New Immunoassay Module Launched Doubling Immunochemistry Tests
Urinary ELISA Kit Developed for Alzheimer's Disease Diagnosis
New Methods Detect Early Onset of Alzheimer's Disease
Simple Method Developed to Characterize Immune Cells in Tumors
Aggressive Breast Cancer Identified with Fluorescent Technique
Parkinson's Disease Biomarker Found in Urinary Samples
Potential Biomarker Found for Severe Viral Hemorrhagic Fevers
Low-Cost Genetic Test Can Distinguish Bacterial from Viral Infections
The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.